Company Filing History:
1 out of 13 
1 out of 61 
1 out of 1,744 
Years Active: 2018
Title: Rajaa Boulahjar: Innovator in Pharmaceutically Acceptable Compounds
Introduction: Rajaa Boulahjar is a notable inventor based in Lille, France, known for his contributions to the field of pharmaceutical chemistry. With a focus on novel compounds, Boulahjar has successfully secured a patent that facilitates advancements in medical therapies.
Latest Patents: Boulahjar's significant patent, focused on "2-oxo-3,4-dihydropyridine-5-carboxylates and their use," introduces novel compounds that can serve as therapeutic agents. This invention emphasizes the development of pharmaceutically acceptable salts or solvates, underscoring Boulahjar’s impact on improving medicinal compounds.
Career Highlights: Throughout his career, Rajaa Boulahjar has worked with reputable institutions. He has been associated with Université de Lille 2 Droit et Santé, where his legal understanding of health sciences enhances his innovative capabilities. Additionally, his tenure at Institut Pasteur de Lille has further solidified his expertise in pharmaceutical research.
Collaborations: Rajaa Boulahjar has collaborated with esteemed colleagues, including Julie Charton and Benoit Deprez. Their joint efforts reflect a commitment to advancing research and development in medicinal chemistry, fostering an enriching environment for innovation.
Conclusion: Rajaa Boulahjar stands as a prominent figure in the development of novel pharmaceutical compounds. His patent portfolio, combined with strategic collaborations, highlights his significant contributions to the field of pharmacology and reflects the potential for future innovations in medicine.